Diagnose and treat 90% of HIV-infected people to an undetectable HIV RNA level by 2020: are we anywhere close? Image ©Patpitchaya/Shutterstock.com
10 New Drugs for Primary Care: Q2 2017
Slide Show: FDA drug approvals in the second quarter 2017 included these 10 for conditions seen in the primary care setting.
Lactic Acidosis in an Infant Receiving HIV Prophylaxis
Zidovudine is safe and effective in reducing transmission of HIV from mother to infant but rare serious side effects do occur. Is it worth the risk?
A Severe Pruritic Rash
What is the cause of this severe rash in a 60-year-old man with HIV?
Politics Govern Treatment and More Medical News
Do doctors’ politics affect treatment decisions on, for example, drug use, firearms, and sexual behavior? Do yours?
The Sexual History is Important, Very Important
Taking a detailed sexual history can be uncomfortable, but it's critical in an HIV/AIDS patient. There is too often a devil deep in those details.
On Demand Pre-Exposure Prophylaxis
Intermittent (vs daily) pre-exposure prophylaxis in men who have unprotected sex with men yielded an 86% relative reduction in new HIV infections in a new study. The caveats?
Unusual Presentations of Primary HIV-1 Infection
Do you know which symptoms might warrant consideration of the acute retroviral syndrome?
Paradigm Shifts in Antiretroviral Therapy
This AIDS specialist predicts that the era of 2-drug regimens will be upon us. He explains why here and writes, "remember: you read about it first here."
90-90-90 by 2020
How far are we from achieving the goal of diagnosing and treating 90% of HIV-infected people to an undetectable HIV RNA level by 2020?
HIV Rx: After Truvada Comes TAF
A new era of antiretroviral therapy was previewed at IDWeek 2015 where results of trials of a "next gen" Truvada were unveiled.